Anti-NIPA1 antibodies are used in the immunodetection of the protein NIPA magnesium transporter 1. In humans, the canonical protein has a reported length of 329 amino acid residues and a mass of 34.6 kDa. Its subcellular localization is in the cell membrane. Up to 2 different isoforms have been reported for this protein. It is reported to be widely expressed with highest levels in neuronal tissues. A member of the NIPA protein family, NIPA1 is known to act as a Mg(2+) transporter. The NIPA1 gene has been associated with the disease, Spastic paraplegia. Synonyms for this target antigen include non imprinted in Prader-Willi/Angelman syndrome 1, non-imprinted in Prader-Willi/Angelman syndrome region protein 1, spastic paraplegia 6 protein, and magnesium transporter NIPA1. NIPA1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Immunofluorescence is the most common application for the NIPA1 antibodies listed below. Western Blot, Immunocytochemistry, and Immunohistochemistry are also common applications.